Bradford D. Dahms insider trades

Open-market stock purchases and sales by Bradford D. Dahms, Chief Financial Officer at Jade Biosciences, Inc, from SEC Form 4 filings since Sep 3, 2019.

Recent trades

DateStockTradeValue
Feb 12, 2026JBIO Jade Biosciences, IncBought (not open market)—
Feb 12, 2026JBIO Jade Biosciences, IncBought (not open market)—

Companies traded

  • JBIO Jade Biosciences, Inc: other filings, last Feb 12, 2026
  • THRX Theseus Pharmaceuticals, Inc: 2 buys, last Feb 14, 2024
  • SELB Selecta Biosciences Inc: other filings, last Jan 4, 2021

Get free alerts when Bradford D. Dahms files a new trade →